These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3032503)

  • 1. In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovir.
    Cole NL; Balfour HH
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):255-61. PubMed ID: 3032503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis.
    Boivin G; Erice A; Crane DD; Dunn DL; Balfour HH
    J Infect Dis; 1993 Aug; 168(2):332-5. PubMed ID: 8393055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening with a shell vial assay for antiviral activity against cytomegalovirus.
    Telenti A; Smith TF
    Diagn Microbiol Infect Dis; 1989; 12(1):5-8. PubMed ID: 2540934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains.
    Prix L; Maierl J; Jahn G; Hamprecht K
    J Clin Virol; 1998 Jul; 11(1):29-37. PubMed ID: 9784141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis.
    Erice A; Borrell N; Li W; Miller WJ; Balfour HH
    J Infect Dis; 1998 Aug; 178(2):531-4. PubMed ID: 9697737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients.
    Erice A; Chou S; Biron KK; Stanat SC; Balfour HH; Jordan MC
    N Engl J Med; 1989 Feb; 320(5):289-93. PubMed ID: 2536135
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates.
    McSharry JJ; Lurain NS; Drusano GL; Landay AL; Notka M; O'Gorman MR; Weinberg A; Shapiro HM; Reichelderfer PS; Crumpacker CS
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2326-31. PubMed ID: 9736557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The folate antagonist, methotrexate, is a potent inhibitor of murine and human cytomegalovirus in vitro.
    Shanley JD; Debs RJ
    Antiviral Res; 1989 Mar; 11(2):99-106. PubMed ID: 2543289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
    Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ
    J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acyclovir combined with other antiviral agents on human cytomegalovirus.
    Spector SA; Tyndall M; Kelley E
    Am J Med; 1982 Jul; 73(1A):36-9. PubMed ID: 6179416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall R; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Jun; 14(2):155-64. PubMed ID: 11704769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro.
    Mar EC; Cheng YC; Huang ES
    Antimicrob Agents Chemother; 1983 Oct; 24(4):518-21. PubMed ID: 6316844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein.
    Michel D; Höhn S; Haller T; Jun D; Mertens T
    J Med Virol; 2001 Sep; 65(1):70-6. PubMed ID: 11505446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of acycloguanosine and trifluorothymidine as inhibitors of cytomegalovirus infection in vitro.
    Lang DJ; Cheung KS
    Am J Med; 1982 Jul; 73(1A):49-53. PubMed ID: 6285732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis.
    Boivin G; Erice A; Crane DD; Dunn DL; Balfour HH
    Antimicrob Agents Chemother; 1993 Feb; 37(2):357-9. PubMed ID: 8383946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity and mechanism of action of ganciclovir.
    Matthews T; Boehme R
    Rev Infect Dis; 1988; 10 Suppl 3():S490-4. PubMed ID: 2847285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
    Plotkin SA; Drew WL; Felsenstein D; Hirsch MS
    J Infect Dis; 1985 Oct; 152(4):833-4. PubMed ID: 2995505
    [No Abstract]   [Full Text] [Related]  

  • 18. Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates.
    McSharry JM; Lurain NS; Drusano GL; Landay A; Manischewitz J; Nokta M; O'Gorman M; Shapiro HM; Weinberg A; Reichelderfer P; Crumpacker C
    J Clin Microbiol; 1998 Apr; 36(4):958-64. PubMed ID: 9542916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94.
    McSharry JJ; McDonough A; Olson B; Talarico C; Davis M; Biron KK
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1279-81. PubMed ID: 11687477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic features of cytomegalovirus retinopathy after treatment with the antiviral agent ganciclovir.
    Pepose JS; Newman C; Bach MC; Quinn TC; Ambinder RF; Holland GN; Hodstrom PS; Frey HM; Foos RY
    Ophthalmology; 1987 Apr; 94(4):414-24. PubMed ID: 3035452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.